StonvexLoading…
StonvexStonvexStonvexCore line items from KMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $1.97B | $2.05B | $2.08B | $2.01B |
Operating Income | $143.12M | $170.22M | $192.42M | $218.14M |
Net Income | $93.13M | $109.32M | $118.46M | $144.62M |
EPS (Diluted) | $1.20 | $1.37 | $1.46 | $1.72 |
Total Assets | $2.55B | $2.50B | $2.55B | $2.57B |
Total Liabilities | $1.22B | $1.22B | $1.23B | $1.28B |
Cash & Equivalents | $140.54M | $127.97M | $106.02M | $85.59M |
Free Cash Flow OCF − CapEx | $119.35M | $169.55M | $163.56M | $-278.37M |
Shares Outstanding | 77.89M | 79.97M | 81.40M | 83.94M |